Increased hyaluronan synthase-2 mRNA expression and hyaluronan accumulation with choroidal thickening: Response during recovery from induced myopia

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6172-6179

  Rada, Jody A Summers ^a,b   Wiechmann, Allan F ^a,b   Hollaway, Lindsey R ^a   Baggenstoss, Bruce A ^a   Weige, Paul H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONAN SYNTHASE 2; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; MESSENGER RNA; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CHOROID; CHOROID THICKENING; CHOROID VASCULARIZATION; CONTROLLED STUDY; CONVALESCENCE; DISEASE DURATION; MOLECULAR SIZE; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE STRUCTURE; VISUAL SYSTEM PARAMETERS;

ANIMALS; ANIMALS, NEWBORN; CHICKENS; CHOROID; CHROMATOGRAPHY, GEL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYPERTROPHY; MALE; MYOPIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSORY DEPRIVATION;

EID: 79955163484     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5522     Document Type: Article

References (66)

1. O'Leary DJ, Millodot M. Eyelid closure causes myopia in humans. Experientia. 1979;35:1478-1479.
2. Rabin J, Van Sluyters RC, Malach R. Emmetropization: a visiondependent phenomenon. Invest Ophthalmol Vis Sci. 1981;20: 561-564.
3. Rasooly R, BenEzra D. Congenital and traumatic cataract: the effect on ocular axial length. Arch Ophthalmol. 1988;106:1066-1068.
4. Twomey JM, Gilvarry A, Restori M, Kirkness CM, Moore AT, Holden AL. Ocular enlargement following infantile corneal opacification. Eye. 1990;4:497-503.
5. Rada JA, Shelton S, Norton TT. The sclera and myopia. Exp Eye Res. 2006;82:185-200.
6. Goss DA, Criswell MH. Myopia development in experimental animals: a literature review. Am J Optom Physiol Opt. 1981;58: 859-869.
7. Schaeffel F, Glasser A, Howland HC. Accommodation, refractive error and eye growth in chickens. Vision Res. 1988;28:639-657.
8. Wallman J, Adams JI. Developmental aspects of experimental myopia in chicks: susceptibility, recovery and relation to emmetropization. Vision Res. 1987;27:1139-1163.
9. Winawer J, Wallman J. In a matter of minutes, the eye can know which way to grow. Invest Ophthalmol Vis Sci. 2005;46:2238- 2241.
10. Wildsoet CF, Schmid KL. Optical correction of form deprivation myopia inhibits refractive recovery in chick eyes with intact or sectioned optic nerves. Vision Res. 2000;40:3273-3282.
11. Troilo D, Gottlieb MD, Wallman J. Visual deprivation causes myopiain chicks with optic nerve section. Curr Eye Res. 1987;6:993- 999.
12. De Stefano ME, Mugnaini E. Fine structure of the choroidal coat of the avian eye: lymphatic vessels. Invest Ophthalmol Vis Sci. 1997; 38:1241-1260.
13. De Stefano ME, Mugnaini E. Fine structure of the choroidal coat of the avian eye: vascularization, supporting tissue and innervation. Anat Embryol. 1997;195:393-418.
14. Junghans BM, Crewther SG, Liang H, Crewther DP, Wareing L, Pirie B. Lymphatics in the chick choroid? Aust N Z J Ophthalmol. 1996;24:47-49.
15. Junghans BM, Crewther SG, Liang H, Crewther DP. A role for choroidal lymphatics during recovery from form deprivation myopia. Optom Vis Sci. 1999;76:796-803.
16. Wallman J, Wildsoet C, Xu A, et al. Moving the retina: choroidal modulation of refractive state. Vision Res. 1995;35:37-50.
17. Liang H, Crewther SG, Crewther DP, Pirie B. Morphology of the recovery from form deprivation myopia in the chick. Aust N Z J Ophthalmol. 1996;24:41-44.
18. Rada JA, Huang Y, Rada KG. Identification of choroidal ovotransferrin as a potential ocular growth regulator. Curr Eye Res. 2001; 22:121-132.
19. Rada JA, McFarland AL, Cornuet PK, Hassell JR. Proteoglycan synthesis by scleral chondrocytes is modulated by a vision dependent mechanism. Curr Eye Res. 1992;11:767-782.
20. Hung LF, Wallman J, Smith EL 3rd. Vision-dependent changes in the choroidal thickness of macaque monkeys. Invest Ophthalmol Vis Sci. 2000;41:1259-1269.
21. Siegwart JT Jr, Norton TT. The susceptible period for deprivationinduced myopia in tree shrew. Vision Res. 1998;38:3505-3515.
22. Troilo D, Nickla DL, Wildsoet CF. Choroidal thickness changes during altered eye growth and refractive state in a primate. Invest Ophthalmol Vis Sci. 2000;41:1249-1258.
23. Weigel PH, DeAngelis PL. Hyalurona n synthases: a decade-plus ofnovel glycosyltransferases. J Biol Chem. 2007;282:36777-36781.
24. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem. 1997;272:13997-14000.
25. Rada JA, Thoft RA, Hassell JR. Increased aggrecan (cartilage proteoglycan) production in the sclera of myopic chicks. Dev Biol. 1991;147:303-312.
26. Shelton LS, Rada JS. Effects of cyclic mechanical stretch on extracellular matrix synthesis by human scleral fibroblasts. Exp Eye Res. 2007;84:314-322.
27. Simon P. Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics. 2003;19:1439-1440.
28. Knudson CB, Toole BP. Fluorescent morphological probe for hyaluronate. J Cell Biol. 1985;100:1753-1758.
29. Underhill CB, Zhang L. Analysis of hyaluronan using biotinylated hyaluronan-binding proteins. Methods Mol Biol. 2000;137:441- 447.
30. Shibata S, Fukada K, Imai H, Abe T, Yamashita Y. In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage. J Anat. 2003;203:425-432.
31. Toole BP, Yu Q, Underhill CB. Hyaluronan and hyaluronan-binding proteins: probes for specific detection. Methods Mol Biol. 2001; 171:479-485.
32. Yamada K. Effects of novel (streptomyces) hyaluronidase digestion upon some mucosaccharide stainings of the cartilages and aortas in the rabbit and rat. Histochemie. 1971;27:277-289.
33. Baggenstoss BA, Weigel PH. Size exclusion chromatography-multiangle laser light scattering analysis of hyaluronan size distributions made by membrane-bound hyaluronan synthase. Anal Biochem. 2006;352:243-251.
34. Rada JA, Wiechmann AF. Ocular expression of avian thymic hormone: changes during the recovery from induced myopia. Mol Vis. 2009;15:778-792.
35. Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999;274:25085-25092.
36. Brinck J, Heldin P. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res. 1999;252:342-351.
37. Köprunner M, Müllegger J, Lepperdinger G. Synthesis of hyaluronan of distinctly different chain length is regulated by differential expression of Xhas1 and 2 during early development of Xenopus laevis. Mech Dev. 2000;90:275-278.
38. Monslow J, Williams JD, Guy CA, et al. Identification and analysis of the promoter region of the human hyaluronan synthase 2 gene. J Biol Chem. 2004;279:20576-20581.
39. Guo N, Kanter D, Funderburgh ML, Mann MM, Du Y, Funderburgh JL. A rapid transient increase in hyaluronan synthase-2 mRNA initiates secretion of hyaluronan by corneal keratocytes in response to transforming growth factor beta. J Biol Chem. 2007;282: 12475-12483.
40. Saavalainen K, Pasonen-Seppänen S, Dunlop TW, Tammi R, Tammi MI, Carlberg C. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. J Biol Chem. 2005;280:14636-14644.
41. Udabage L, Brownlee GR, Nilsson SK, Brown TJ. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res. 2005;310:205-217.
42. Bakkers J, Kramer C, Pothof J, Quaedvlieg NE, Spaink HP, Hammerschmidt M. Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation. Development. 2004;131:525-537.
43. Murata M, Horiuchi S. Hyaluronan synthases, hyaluronan and its CD44 receptors in the posterior segment of rabbit eye. Ophthalmologica. 2005;219:287-291.
44. Usui T, Amano S, Oshika T, et al. Expression regulation of hyaluronan synthase in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2000;41:3261-3267.
45. Usui T, Nakajima F, Ideta R, Kaji, et al. Hyaluronan synthase in trabecular meshwork cells. Br J Ophthalmol. 2003;87:357-360.
46. Itano N. Simple primary structure, complex turnover regulation and multiple roles of hyaluronan. J Biochem. 2008;144:131-137.
47. Weigel PH, Yik JHN. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta. 2002;1572:341-363.
48. Laurent TC, Fraser JRE. Hyaluronan. FASEB J. 1992;6:2397-2404.
49. Weigel JA, Raymond RC, McGary CT, Singh A, Weigel PH. A blocking antibody to the hyaluronan (HA) receptor for endocytosis (HARE) inhibits HA clearance by perfused liver. J Biol Chem. 2003;278:9802-9812.
50. Zhou B, Weigel JA, Fauss L, Weigel PH. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem. 2000; 275:37733-37741.
51. Harris EN, Weigel JA, Weigel PH. Endocytic function, glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa HARE. J Biol Chem. 2004;279:36201-36209.
52. Harris EN, Weigel JA, Weigel PH. The human hyaluronan receptor for endocytosis (HARE) is a systemic clearance receptor for heparin. J Biol Chem. 2008;283:17341-17350.
53. Toole BP, Trelstad RL. Hyaluronate production and removal during corneal development in the chick. Dev Biol. 1971;26:28 -35.
54. Li Y, Toole BP, Dealy CN, Kosher RA. Hyaluronan in limb morphogenesis. Dev Biol. 2007;305:411-420.
55. Inoue Y, Yoneda M, Miyaishi O, Iwaki M, Zako M. Hyaluronan dynamics during retinal development. Brain Res. 2009;1256: 55- 60.
56. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronan. Science. 1985;228:1324-1326.
57. Toole BP, Slomiany MG. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol. 2008;18:244-250.
58. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002;21:25-29.
59. Almond A. Hyaluronan. Cell Mol Life Sci. 2007;64:1591-1596.
60. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4:528 -539.
61. Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci. 2007;80:1921-1943.
62. Suzuki K, Yamamoto T, Usui T, Suzuki K, Heldin P, Yamashita H. Expression of hyaluronan synthase in intraocular proliferative diseases: regulation of expression in human vascular endothelial cells by transforming growth factor-beta. Jpn J Ophthalmol. 2003; 47:557-564.
63. Mertz JR, Wallman J. Choroidal retinoic acid synthesis: a possible mediator between refractive error and compensatory eye growth. Exp Eye Res. 2000;70:519-527.
64. Seko Y, Shimokawa H, Tokoro T. Expression of bFGF and TGF-beta 2 in experimental myopia in chicks. Invest Ophthalmol Vis Sci. 1995;36:1183-1187.
65. Honda S, Fujii S, Sekiya Y, et al. Retinal control on the axial length mediated by transforming growth factor-beta in chick eye. Invest Ophthalmol Vis Sci. 1996;37:2519-2526.
66. Jobling AI, Nguyen M, Gentle A, et al. Isoform-specific changes in scleral transforming growth factor-beta expression and the regulation of collagen synthesis during myopia progression. J Biol Chem. 2004;279:18121-126.